Oct 19, 2026 02:21PM
Sep 22, 2026 07:54AM
Sep 22, 2026 07:36AM
Aug 31, 2026 05:37AM
Aug 25, 2026 07:37AM
Jun 10, 2026 06:44AM
May 12, 2026 05:16PM AnaptysBio, Inc. (ANAB) Misses Q1 EPS by 88c
Apr 24, 2026 03:41PM
Apr 24, 2026 07:19AM
Apr 21, 2026 09:25AM
Apr 20, 2026 09:16AM
Mar 31, 2026 09:35AM
Mar 31, 2026 06:42AM
Mar 17, 2026 06:13AM AnaptysBio (ANAB) PT Raised to $90 at UBS
Mar 6, 2026 09:07AM
Mar 5, 2026 07:51AM
Mar 4, 2026 06:45AM
Mar 4, 2026 05:48AM
Mar 3, 2026 04:38PM
Feb 25, 2026 07:19AM
Jan 12, 2026 09:55AM AnaptysBio (ANAB) Reiterated at Buy by UBS: Trial Now Set for July 2026
Jan 12, 2026 04:05AM
Jan 8, 2026 06:03PM
Jan 7, 2026 12:39AM
Dec 19, 2025 09:06AM
Dec 15, 2025 07:01AM
Dec 11, 2025 07:38AM
Nov 26, 2025 04:05PM AnaptysBio files lawsuit against Tesaro and GSK over license deal
Nov 21, 2025 03:56AM
Nov 10, 2025 09:00AM
Nov 10, 2025 08:57AM
Oct 29, 2025 09:15AM
Oct 15, 2025 07:24AM
Oct 14, 2025 06:29AM
Oct 13, 2025 09:16AM AnaptysBio to present rosnilimab rheumatoid arthritis data at ACR meeting
Oct 13, 2025 05:29AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 30, 2025 10:19AM
Sep 30, 2025 06:48AM
Sep 30, 2025 06:44AM
Sep 29, 2025 04:07PM Anaptys plans split into royalty and biopharma companies by 2026
Sep 29, 2025 04:01PM
Sep 17, 2025 07:41AM
Aug 7, 2025 06:20AM
Jun 4, 2025 07:15AM
Jun 4, 2025 06:27AM
Jun 4, 2025 06:06AM
Jun 3, 2025 04:07PM Anaptysbio (ANAB) Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
May 28, 2025 07:10AM

470,321 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All